Healthcare -
Biotechnology - NASDAQ - US
$ 1.02
-2.17 %
$ 57.6 M
Market Cap
-0.58
P/E
PRLD - NET INCOME
Net Income PRLD - Prelude Therapeutics Incorporated
-127 M
LAST VALUE
-4.96%
2 YEAR CAGR
-35.77%
5 YEAR CAGR
0.00%
10 YEAR CAGR